scholarly journals Once daily intravenous (IV) busulfan (Bu) containing preparative regimens for hematopoietic stem cell transplantation (HSCT): Low incidence of Hepatic Veno-Occlusive Disease (HVOD) and improved early survival in a single center’s experience

2005 ◽  
Vol 11 (2) ◽  
pp. 31
Author(s):  
H. Benn ◽  
A. Amin ◽  
H.-C. Susan ◽  
D. Kramek ◽  
N. Janbay ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document